When prescribing basal insulin, did you know you have another U-100 option? Watch this video to find out why Tresiba® FlexTouch® U-100 may be a more appropriate option for your patients 1 year of age and older with diabetes.
Start your patients new to insulin on their journey with Tresiba®
More administration options than any other basal insulin1-5
Tresiba® FlexTouch® U‑1001
The U-100 you're familiar with

Pen contains 300 total units
Delivers a maximum dose of 80 units in a single injection
1-unit dose adjustments
Tresiba® FlexTouch®
U‑2001
Same dose in half the volume of U-100

Pen contains 600 total units
Patients who need higher doses can take up to 160 units in a single injection
2-unit dose adjustments
Tresiba® U-100 multiple-dose 10-mL vial1
For patients who prefer vials

Vial contains 1000 total units
Use vial only with a U-100 insulin syringe
Unit dosing remains the same, no matter which administration option you prescribe

Tresiba® has one of the longest in-use times of any once-daily, long-acting basal insulin1-4


aOpened (in-use) Tresiba® should be refrigerated (36°F to 46°F [2°C to 8°C]) or kept at room temperature (below 86°F [30°C]), away from direct heat and light.1
bOpened (in-use) Lantus® SoloSTAR® devices must be discarded 4 weeks after being opened. Once in use, the device must be kept at room temperature and should not be refrigerated.2
cThe in-use insulin glargine U-100 vial must be discarded after 4 weeks and the in-use insulin detemir pen and vial must be discarded after 6 weeks.2,3
